 NeoGenomics, Inc. NASDAQ:NEO Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Lynn Tetrault - Executive Chair Principal Executive Officer William Bonello - Chief Financial Officer Doug Brown - Chief Strategy and Corporate Development Officer Charlie Eidson - Director, Investor Relations Shashi Kulkarni - Chief Scientific Officer David Sholehvar - Clinical Division President Conference Call Participants Brian Weinstein - William Blair Matt Sykes - Goldman Sachs Andrew Cooper - Raymond James Alex Nowak - Craig Hallum Capital Mark Massaro - BTIG Puneet Souda - SVB Securities Dan Brennan - Cowen Operator Good morning ladies and gentlemen. Thank you for standing by. 